Stock listing
Kaken Pharmaceutical Co., Ltd.
Selected listing: 4521 · TSE · JPY · JP
Kaken Pharmaceutical Co., Ltd. (Tokyo:4521), Health Technology. Latest release Aug 7, 2026: [Summary] Consolidated Financial Results for the Three-Months…
- Ticker
- Tokyo:4521
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tokyo
- Currency
- JPY
About Kaken Pharmaceutical Co., Ltd.
Kaken Pharmaceutical Co., Ltd. is a publicly traded company in Japan, listed under the ticker 4521. Kaken focuses on developing and providing innovative pharmaceutical products to improve patient health.
Latest news from Kaken Pharmaceutical Co., Ltd.
[Summary] Consolidated Financial Results for the Three-Months Period of Fiscal 2026 (Three-Month Period Ended June 30, 2026) [JGAAP]
August 7, 2026
Kaken Pharmaceutical : Consolidated Financial Results for the Fiscal Year 2025
May 13, 2026
Kaken Pharmaceutical : Supplementary Financial Information of Financial Statements Fiscal 2025
May 13, 2026
KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
March 25, 2026
Kaken Pharmaceutical : Consolidated Financial Results for the Nine Months Period of Fiscal 2025 (Nine Month Period Ended December 31, 2025)
February 6, 2026
Research Kaken Pharmaceutical Co., Ltd.
Kaken Pharmaceutical Co., Ltd. company profile
View the public company page for Kaken Pharmaceutical Co., Ltd. on 6ix.
Kaken Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Kaken Pharmaceutical Co., Ltd..
Kaken Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Kaken Pharmaceutical Co., Ltd..